Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In the SURMOUNT-1 clinical trial, tirzepatide produced up to 23% body weight loss, outperforming every prior pharmacological treatment
Shoaib, M., Khaliq, H
Individuals with Fitzpatrick skin types I and II have shown the greatest increase in pigmentation in clinical studies
Clinical evidence shows this peptide can reduce wrinkle depth by up to 20% within twelve weeks without the irritation that retinoids sometimes cause
Curr Opin Immunol 2014;29, 9396, doi: Bryant, A
Hypoglycaemia can occur, particularly when GLP-1 agonists are used in combination with insulin or sulphonylureas, though the risk is lower when used as monotherapy due to their glucose-dependent mechanism
US$ 23.20
US$ 23.31
US$ 23.62
US$ 29.55
